GLP-1 rival Novo Nordisk is developing its own triple-G candidates and recently secured regulatory backing for a higher-dose formulation of Wegovy in the European Union.
The demand for these drugs is soaring, and insurers are continuing to not cover these drugs, expecting and pushing patients to buy them online and pay in cash, but those compounding pharmacies are so dangerous
Common GLP-1 side effects The most common GLP-1 side effects tend to occur when you first start taking the medication or when there is a prescribed increase in your dose
Chalasani 3 and Malaz Boustani 1 , (1)Indiana University, (2)Purdue University, (3)Indiana University Medical Center, Indianapolis, IN Background: Patients with decompensated cirrhosis have poor quality of life and complex care needs that could be addressed with existing services
It's too much insulin rather than too little insulin